Lunai Bioworks Inc. — Director's Dealing 2017

Oct 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DanDrit Biotech USA, Inc. (DDRT)
CIK: 0001527728
Period of Report: 2017-10-13

Reporting Person: Sindlev Rene (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-13	Warrants to purchase shares of common stock	$2.00	P	250000	Acquired	2019-12-31	Common Stock (250000)	Indirect

Footnotes

F1: On October 13, 2017, RS Group ApS, an entity controlled by Mr. Sindlev, purchased 250,000 warrants to purchase shares of common stock of Dandrit Biotech USA, Inc. in a private transaction.